{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:26:32Z","timestamp":1793042792919,"version":"4.5.0"},"reference-count":106,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Psychopharmacology"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>\n                    Schizophrenia is a devastating mental disorder resulting in marked morbidity and mortality despite the optimal use of all currently available interventions. For this reason, the release of lumateperone (Captyla\n                    <jats:sup>R<\/jats:sup>\n                    ), also known as ITI-007, an orally administered, atypical antipsychotic provided a welcome novel tool for clinicians to utilize precision medicine to tailor an optimal treatment plan to the specific needs of each person with schizophrenia. To generate a foundation for clinicians to assess the risks and benefits of lumateperone in relation to other interventions for schizophrenia, we conducted a search of items for \u2018ITI-007\u2019 and \u2018lumateperone\u2019 on PubMed, ScienceDirect, Web of Science, Google Scholar, and www.clinicaltrials.gov . We present a critical evaluation of the limited information about lumateperone for schizophrenia, its use approved by the US Food and Drug Administration. Lumateperone merits consideration for patients with treatment-resistant schizophrenia and for patients with schizophrenia who are vulnerable to developing metabolic dysfunction and movement disorders. On the other hand, lumateperone should not be used for (a) women who are pregnant or breastfeeding, children, adolescents, and elderly patients with dementia-related psychosis, (b) patients who are at risk for cerebrovascular diseases, (c) patients who use inducers and moderate or strong inhibitors of the cytochrome P450-3A4 (CYP3A4) isozyme, and (d) patients who use alcohol and other sedating agents. Clinical trials from multiple centers without financial conflicts of interest to market lumateperone are needed to directly compare and contrast lumateperone and other antipsychotic agents to generate trustworthy evidence to be assessed objectively by clinicians treating patients with schizophrenia. Future investigations will provide the foundations to identify the evidence for comprehensive evaluations of the role of lumateperone in the treatment of people with schizophrenia and other conditions.\n                  <\/jats:p>","DOI":"10.1177\/20451253211034019","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T07:45:50Z","timestamp":1627717550000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":30,"title":["The role of lumateperone in the treatment of schizophrenia"],"prefix":"10.1177","volume":"11","author":[{"given":"Alveena Batool","family":"Syed","sequence":"first","affiliation":[{"name":"Liaquat University of Medical & Health Sciences, Jamshoro, Sindh, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3948-4853","authenticated-orcid":false,"given":"James Robert","family":"Bra\u0161i\u0107","sequence":"additional","affiliation":[{"name":"Section of High Resolution Brain Positron Emission Tomography Imaging, Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, 1101 Saint Paul Street, Unit 1107, Baltimore, MD 21202-2664, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,7,31]]},"reference":[{"key":"bibr1-20451253211034019","unstructured":"National Institute of Mental Health. Schizophrenia. www.nimh.nih.gov\/health\/topics\/schizophrenia\/index.shtml (2020, accessed 15 July 2021)."},{"key":"bibr2-20451253211034019","volume-title":"Scale for the assessment of positive symptoms (SAPS). Rating scale","author":"Andreasen NC.","year":"1984"},{"key":"bibr3-20451253211034019","unstructured":"D\u2019Arrigo T. Schizophrenia symptoms. WebMD, www.webmd.com\/schizophrenia\/schizophrenia-symptoms (2020, accessed 15 July 2021)."},{"key":"bibr4-20451253211034019","volume-title":"Scale for the assessment of negative symptoms (SANS). Rating scale","author":"Andreasen NC.","year":"1984"},{"key":"bibr5-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1695778"},{"key":"bibr6-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1177\/2045125318781475"},{"key":"bibr7-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32154-2"},{"key":"bibr8-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxn001"},{"key":"bibr9-20451253211034019","doi-asserted-by":"publisher","DOI":"10.3109\/09540261.2010.515205"},{"key":"bibr10-20451253211034019","first-page":"30","volume":"3","author":"Bra\u0161i\u0107 JR.","year":"2013","journal-title":"J Biomed Graph Comput"},{"key":"bibr11-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-007-0041-7"},{"issue":"57","key":"bibr12-20451253211034019","first-page":"60","volume":"22","author":"Wong DF","year":"2005","journal-title":"Psychiatr Times"},{"key":"bibr13-20451253211034019","first-page":"1519","volume-title":"Kaplan & Sadock\u2019s comprehensive textbook of psychiatry","author":"Wong DF","year":"2009","edition":"9"},{"key":"bibr14-20451253211034019","first-page":"78","volume-title":"Understanding neuropsychiatric disorders: insights from neuroimaging","author":"Wong DF","year":"2011"},{"key":"bibr15-20451253211034019","first-page":"1488","volume-title":"Kaplan & Sadock\u2019s comprehensive textbook of psychiatry","author":"Wong DF","year":"2017","edition":"10"},{"key":"bibr16-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320937575"},{"key":"bibr17-20451253211034019","first-page":"3170","volume-title":"Kaplan & Sadock\u2019s comprehensive textbook of psychiatry","author":"Marder SR","year":"2017","edition":"10"},{"key":"bibr18-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.08.026"},{"key":"bibr19-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.20200051"},{"key":"bibr20-20451253211034019","first-page":"3059","volume-title":"Kaplan & Sadock\u2019s comprehensive textbook of psychiatry","author":"Strassnig MT","year":"2017","edition":"10"},{"key":"bibr21-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-015-3922-1"},{"key":"bibr22-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852916000729"},{"key":"bibr23-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.05.006"},{"key":"bibr24-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01271-6"},{"key":"bibr25-20451253211034019","volume-title":"StatPearls","author":"Cooper D.","year":"2021"},{"key":"bibr26-20451253211034019","first-page":"113","volume":"62","author":"Lumateperone (Caplyta) for schizophrenia","year":"2020","journal-title":"Med Lett Drugs Ther"},{"key":"bibr27-20451253211034019","first-page":"32","volume":"50","author":"Edinoff A","year":"2020","journal-title":"Psycholpharmacol Bull"},{"key":"bibr28-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1007\/s40267-020-00780-4"},{"key":"bibr29-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1177\/1060028020936597"},{"key":"bibr30-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2018.54.12.2899443"},{"key":"bibr31-20451253211034019","doi-asserted-by":"publisher","DOI":"10.2174\/1871527319666200601145653"},{"key":"bibr32-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2019.07.001"},{"key":"bibr33-20451253211034019","first-page":"9","volume":"48","author":"Limandri BJ.","year":"2020","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"bibr34-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1002\/9780470712184"},{"key":"bibr35-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2020.02.008"},{"key":"bibr36-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2016.1174577"},{"key":"bibr37-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1002\/pnp.430"},{"key":"bibr38-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1021\/jm401958n"},{"key":"bibr39-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2020.09.001"},{"key":"bibr40-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3704-1"},{"key":"bibr41-20451253211034019","first-page":"1043","volume":"204","author":"Guillin O.","year":"2020","journal-title":"Bull Acad Natl Med"},{"key":"bibr42-20451253211034019","unstructured":"Center for Drug Evaluation and Research. Approval package for: application number: 209500Orig1s000 2019. Silver Spring, MD: Food and Drug Administration, 2019. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/209500Orig1s000Approv.pdf (2019, accessed 15 July 2021)."},{"key":"bibr43-20451253211034019","unstructured":"Intra-Cellular Therapies Inc. Caplyta (lumateperone) capsules, for oral use (package insert). New York: Intra-Cellular Therapies, Inc. https:\/\/www.intracellulartherapies.com\/docs\/caplyta_pi.pdf (2019, accessed 15 July 2021)."},{"key":"bibr44-20451253211034019","volume-title":"4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3\u2032,4\u2032:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals","author":"Tomesch J","year":"2015"},{"key":"bibr45-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852919000245"},{"key":"bibr46-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0251-1"},{"key":"bibr47-20451253211034019","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbz020.662","volume":"45","author":"Vanover K","year":"2019","journal-title":"Schizophr Bull"},{"key":"bibr48-20451253211034019","first-page":"S416","volume":"42","author":"Vanover K","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"bibr49-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbz020.662"},{"key":"bibr50-20451253211034019","first-page":"1","author":"Zhang L","year":"2018","journal-title":"Matters"},{"key":"bibr51-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2017.1323870"},{"key":"bibr52-20451253211034019","volume":"42","author":"Svensson T","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"bibr53-20451253211034019","doi-asserted-by":"publisher","DOI":"10.2147\/JEP.S259317"},{"key":"bibr54-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2020.09.428"},{"key":"bibr55-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.4265"},{"key":"bibr56-20451253211034019","first-page":"42","volume":"20","author":"Farah A.","year":"2021","journal-title":"Curr Psychiatr"},{"key":"bibr57-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2020.101976"},{"key":"bibr58-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-021-00198-3"},{"key":"bibr59-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpmed.2016.04.009"},{"key":"bibr60-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1795126"},{"key":"bibr61-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.4379"},{"key":"bibr62-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2020.01.030"},{"key":"bibr63-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"bibr64-20451253211034019","unstructured":"Guy W. Assessment manual for psychopharmacology revised. DHEW Publication No. (ADM)76-338. Rockville, MD: US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, 1976, pp.217\u2013222."},{"key":"bibr65-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-0753-5_2141"},{"key":"bibr66-20451253211034019","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n1205"},{"key":"bibr67-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sby017.577"},{"key":"bibr68-20451253211034019","author":"Satlin A","year":"2019","journal-title":"58th Annual Meeting of the American College of Neuropsychopharmacology"},{"key":"bibr69-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1192\/S0007125000292581"},{"key":"bibr70-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2019.09.644"},{"key":"bibr71-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2020.12.006"},{"key":"bibr72-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2020.09.345"},{"key":"bibr73-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2019.09.642"},{"key":"bibr74-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0428-x"},{"key":"bibr75-20451253211034019","volume":"26","author":"Maroney M.","year":"2020","journal-title":"Am J Manag Care"},{"key":"bibr76-20451253211034019","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S282856"},{"key":"bibr77-20451253211034019","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01003"},{"key":"bibr78-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13266"},{"key":"bibr79-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2019.06.008"},{"key":"bibr80-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1017\/S109285291900124X"},{"key":"bibr81-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.0610"},{"key":"bibr82-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.0613"},{"key":"bibr83-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31135-3"},{"key":"bibr84-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3"},{"key":"bibr85-20451253211034019","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00622"},{"key":"bibr86-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320957119"},{"key":"bibr87-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320982720"},{"key":"bibr88-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320964097"},{"key":"bibr89-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.01.005"},{"key":"bibr90-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2018.12.017"},{"key":"bibr91-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1586\/ern.10.160"},{"key":"bibr92-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-418679-8.00010-1"},{"key":"bibr93-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-418677-4.00015-4"},{"key":"bibr94-20451253211034019","unstructured":"Brasic JR, Syed AB, Farhadi F, et al. PET scanning in autism spectrum disorder. Medscape Drug Dis. http:\/\/emedicine.medscape.com\/article\/1155568-overview (2020, accessed 15 July 2021)."},{"key":"bibr95-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-418677-4.00016-6"},{"key":"bibr96-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2017.1397606"},{"key":"bibr97-20451253211034019","doi-asserted-by":"publisher","DOI":"10.3934\/molsci.2019.4.87"},{"key":"bibr98-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1002\/9781118384404.ch24"},{"key":"bibr99-20451253211034019","first-page":"161","volume":"27","author":"Wong DF","year":"2003","journal-title":"Alcohol Res Health"},{"key":"bibr100-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-418677-4.00002-6"},{"key":"bibr101-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1097\/01.SMJ.0000146494.63540.33"},{"key":"bibr102-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1097\/01.rlu.0000233350.01580.c2"},{"key":"bibr103-20451253211034019","first-page":"67","volume":"3","author":"Alexander M","year":"2013","journal-title":"J Biomed Graph Comput"},{"key":"bibr104-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1177\/20451253211012250"},{"key":"bibr105-20451253211034019","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-019-00668-7"},{"key":"bibr106-20451253211034019","doi-asserted-by":"crossref","unstructured":"Iasonos A. Finding optimism in clinical trials: a numbers perspective.\n                      Oncologist\n                      2021; 26: 84\u201385.","DOI":"10.1634\/theoncologist.2020-0543"}],"container-title":["Therapeutic Advances in Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20451253211034019","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20451253211034019","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20451253211034019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:52:30Z","timestamp":1777593150000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20451253211034019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":106,"alternative-id":["10.1177\/20451253211034019"],"URL":"https:\/\/doi.org\/10.1177\/20451253211034019","relation":{},"ISSN":["2045-1253","2045-1261"],"issn-type":[{"value":"2045-1253","type":"print"},{"value":"2045-1261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"article-number":"20451253211034019"}}